FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 206 filers reported holding FATE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,606,000 | +35.1% | 130,000 | +36.8% | 2.10% | +30.0% |
| Q3 2021 | $5,631,000 | -18.9% | 95,000 | +18.8% | 1.62% | -15.3% |
| Q2 2021 | $6,943,000 | +110.5% | 80,000 | +100.0% | 1.91% | +102.9% |
| Q1 2021 | $3,298,000 | -2.9% | 40,000 | -52.9% | 0.94% | -9.3% |
| Q3 2020 | $3,397,000 | +41.4% | 85,000 | +21.4% | 1.04% | +44.5% |
| Q2 2020 | $2,402,000 | +13.8% | 70,000 | -26.3% | 0.72% | -22.6% |
| Q1 2020 | $2,110,000 | – | 95,000 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |